ARTICLE | Company News
Acorda slides on complete response for diazepam nasal spray
May 3, 2014 1:30 AM UTC
Acorda Therapeutics Inc. (NASDAQ:ACOR) was down $3.51 (10%) to $32.39 on Friday after FDA issued a complete response letter for Plumiaz diazepam nasal spray to treat acute repetitive seizures in epile...